These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
Delaware
|
95-4106894
|
|
(State or other jurisdiction
|
(I.R.S. Employer Identification No.)
|
|
of incorporation or organization)
|
|
Large Accelerated Filer
|
Accelerated Filer
|
|
|
Non-accelerated filer
|
Smaller Reporting Company [x]
|
|
Class
|
Outstanding October 10, 2014
|
|
Common Stock, par value $0.0001 per share
|
110,601,032 shares
|
|
Index
|
Page No.
|
||
|
PART I.
|
FINANCIAL INFORMATION
|
||
|
ITEM 1.
|
Financial Statements (Unaudited)
|
||
|
Balance Sheets as of August 31, 2014 and February 28, 2014
|
4
|
||
|
Statements of Operations for the Three and Six months Ended August 31, 2014 and 2013
|
5
|
||
|
Statements of Cash Flows for the Six months Ended August 31, 2014 and 2013
|
6
|
||
|
Notes to Financial Statements
|
7
|
||
|
ITEM 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
14
|
|
|
ITEM 4T.
|
Controls and Procedures
|
19
|
|
|
PART II.
|
OTHER INFORMATION
|
||
|
ITEM 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
19
|
|
|
ITEM 6.
|
Exhibits
|
20
|
|
|
SIGNATURES AND CERTIFICATIONS
|
21
|
||
|
As of August 31, 2014
|
As of February 28, 2014
|
|||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 33,950 | $ | 40,927 | ||||
|
Accounts receivable, net of allowance for doubtful accounts of $50,000 at August 31 and February 28, 2014, respectively
|
207,948 | 125,593 | ||||||
|
Inventory - current
|
1,000,000 | 1,000,000 | ||||||
|
Other current assets
|
54,943 | 100,952 | ||||||
|
Total current assets
|
1,296,841 | 1,267,472 | ||||||
|
Deposits
|
100,138 | 89,138 | ||||||
|
Property, plant, and equipment, net
|
2,175 | 7,954 | ||||||
|
Inventory, non-current, net of allowance for obsolete inventory of $2,284,130 and $2,412,538 at August 31 and February 28, 2014, respectively
|
54,264 | 131,037 | ||||||
|
Total assets
|
$ | 1,453,418 | $ | 1,495,601 | ||||
|
LIABILITIES AND STOCKHOLDERS' DEFICIT
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$ | 1,568,076 | $ | 2,077,513 | ||||
|
Accrued expenses
|
3,259,282 | 3,385,937 | ||||||
|
Customer advances
|
427,911 | 80,641 | ||||||
|
Notes payable
|
1,679,990 | 1,559,990 | ||||||
|
Convertible notes payable, net of discount
|
2,720,700 | 2,567,556 | ||||||
|
Notes payable and accrued interest- related party
|
22,324,825 | 19,730,372 | ||||||
|
Total current liabilities
|
31,980,784 | 29,402,009 | ||||||
|
Convertible note payable, net of discount
|
1,232,430 | 1,187,598 | ||||||
|
Convertible note payable and accrued interest-related party, net of discount
|
1,862,385 | 2,176,005 | ||||||
|
Total liabilities
|
35,075,599 | 32,765,612 | ||||||
|
Stockholders' deficit:
|
||||||||
|
Common stock, $0.0001 par value; 150,000,000 shares authorized at August 31 and February 28, 2014; 110,549,032 and 88,914,499 issued and outstanding at August 31 and February 28, 2014, respectively
|
11,055 | 8,891 | ||||||
|
Additional paid-in capital
|
408,993,726 | 403,234,261 | ||||||
|
Accumulated deficit
|
(442,626,962 | ) | (434,513,163 | ) | ||||
|
Total stockholders' deficit
|
(33,622,181 | ) | (31,270,011 | ) | ||||
|
Total liabilities and stockholders' deficit
|
$ | 1,453,418 | $ | 1,495,601 | ||||
|
Three Months
|
Six Months
|
||||||||||||||||
|
2014
|
2013
|
2014 2013
|
|
||||||||||||||
|
Net Revenues
|
$ | 510,550 | $ | 615,389 | $ | 960,522 | $ | 1,423,915 | |||||||||
|
Cost of goods sold
|
295,791 | 311,735 | 505,850 | 631,955 | |||||||||||||
|
Gross Profit
|
214,759 | 303,654 | 454,672 | 791,960 | |||||||||||||
|
Expenses
|
|||||||||||||||||
|
Engineering, research and development expenses
|
361,371 | 304,902 | 665,374 | 703,700 | |||||||||||||
|
Selling, general and administrative expenses
|
3,132,583 | 2,274,255 | 6,256,929 | 4,839,425 | |||||||||||||
|
Total costs and expenses
|
3,493,954 | 2,579,157 | 6,922,303 | 5,543,125 | |||||||||||||
|
Loss from operations
|
(3,279,195 | ) | (2,275,503 | ) | (6,467,631 | ) | (4,751,165 | ) | |||||||||
|
Other (income) and expense
|
|||||||||||||||||
|
Interest expense, net
|
826,312 | 1,455,568 | 1,651,748 | 2,171,866 | |||||||||||||
|
Other (income) expense, net
|
- | - | (5,580 | ) | (212,717 | ) | |||||||||||
|
Total other (income) expense
|
826,312 | 1,455,568 | 1,646,168 | 1,959,149 | |||||||||||||
|
Net Loss
|
$ | (4,105,507 | ) | $ | (3,731,071 | ) | $ | (8,113,799 | ) | $ | (6,710,314 | ) | |||||
|
Total basic and diluted loss per share
|
$ | (0.04 | ) | $ | (0.04 | ) | $ | (0.08 | ) | $ | (0.08 | ) | |||||
|
Weighted average shares used to
compute basic and diluted income (loss) per share
|
109,847,945 | 84,722,108 | 107,494,204 | 81,121,697 | |||||||||||||
|
2014
|
2013
|
|||||||
|
Cash flow from operating activities:
|
||||||||
|
Net Loss
|
$ | (8,113,799 | ) | $ | (6,710,314 | ) | ||
|
Adjustments to reconcile Net loss to net cash used in operating activities
|
||||||||
|
Depreciation Expense
|
5,780 | 24,530 | ||||||
|
Amortization of debt discount
|
281,364 | 455,860 | ||||||
|
Gain on settlement of debt
|
- | (203,110 | ) | |||||
|
Stock issued for services
|
420,000 | 889,726 | ||||||
|
Stock option and warrant expense
|
3,308,176 | 548,573 | ||||||
|
Provision for inventory obsolescence
|
(128,408 | ) | (93,691 | ) | ||||
|
(Increase) decrease in:
Accounts receivable
|
(82,355 | ) | (256,469 | ) | ||||
|
Inventory
|
205,181 | 300,782 | ||||||
|
Other current assets and deposit
|
35,009 | 8,463 | ||||||
|
Increase (decrease) in:
|
||||||||
|
Accounts payable, customer deposit and accrued expenses
|
556,416 | 1,116,789 | ||||||
|
Net cash used in operations
|
(3,512,636 | ) | (3,918,861 | ) | ||||
|
Financing activities:
|
||||||||
|
Issuance of common stock
|
2,033,453 | - | ||||||
|
Proceeds from notes payable
|
365,000 | 535,000 | ||||||
|
Payments on notes payable
|
(245,000 | ) | (120,000 | ) | ||||
|
Proceeds from convertible notes payable
|
- | 1,170,700 | ||||||
|
Payments on convertible notes payable
|
- | (306,250 | ) | |||||
|
Proceeds from notes payable-related party
|
2,602,206 | 2,582,000 | ||||||
| Payment for notes payable-related party | (750,000 | ) | - | |||||
| Payment for convertible notes payable-related party | (500,000 | ) | - | |||||
|
Net cash provided by financing activities:
|
3,505,659 | 3,861,450 | ||||||
|
Net increase (decrease) in cash & cash equivalents
|
(6,977 | ) | (57,411 | ) | ||||
|
Cash and cash equivalents at beginning of period
|
40,927 | 89,196 | ||||||
|
Cash and cash equivalents at end of period
|
$ | 33,950 | $ | 31,785 | ||||
|
Supplemental disclosures of cash flow information
|
||||||||
|
Cash paid during the period for:
|
||||||||
|
Interest
|
- | $ | 106,842 | |||||
|
Income taxes
|
- | - | ||||||
|
August 31, 2014
|
February 28, 2014
|
|||||||
|
Raw materials
|
$ | 1,816,773 | $ | 1,808,556 | ||||
|
Finished goods
|
1,525,085 | 1,735,019 | ||||||
| 3,341,858 | 3,543,575 | |||||||
|
Reserve for potential product obsolescence
|
(2,287,594 | ) | (2,334,487 | ) | ||||
|
Discount on long term inventory
|
- | (78,051 | ) | |||||
| 1,054,264 | 1,131,037 | |||||||
|
Non-current portion
|
- | (131,037 | ) | |||||
|
Current portion
|
$ | 1,054,264 | $ | 1,000,000 | ||||
|
August 31, 2014
|
February 28, 2014
|
|||||||
|
Machinery and equipment
|
$ | 964,111 | $ | 964,111 | ||||
|
Furniture and fixtures
|
163,302 | 163,302 | ||||||
| 1,127,413 | 1,127,413 | |||||||
|
Less accumulated depreciation
|
(1,125,238 | ) | (1,119,458 | ) | ||||
|
Property, plant and equipment, net
|
$ | 2,175 | $ | 7,955 | ||||
|
August 31, 2014
|
February 28, 2014
|
|||||||
|
Demand notes payable, at 10% and 16%
|
$ | 1,679,990 | $ | 1,559,990 | ||||
|
Convertible Promissory Note dated August 10, 2012, due August 10, 2017, convertible into shares of our common stock at a price of $0.76 per share. The note carries an interest rate of 7% with interest only payments due on the 10
th
of each month with the principal payment due on the maturity date.
|
817,272 | 786,198 | ||||||
|
Convertible Promissory Note dated October 2, 2012, due October 2, 2017, convertible into shares of our common stock at a price of $0.76 per share. The note carries an interest rate of 7% with interest only payments due on the 2
nd
of each month with the principal payment due on the maturity date.
|
415,158 | 401,399 | ||||||
|
Senior secured convertible notes dated May 7, 2013, due June 15, 2013, convertible into shares of our common stock at a price of $0.75 per share. The notes carry an interest rate of 12% with interest due on the last day of the month. If the note is not repaid by the due date, the interest rate increases to 16%.
|
2,395,700 | 2,261,643 | ||||||
|
Senior secured convertible notes dated June 20, 2013, due June 20, 2014, convertible into shares of our common stock at a price of $0.75 per share. The notes carry an interest rate of 16% with interest due on the last day of the month. If the note is not repaid by the due date, the interest rate increases to 16%.
|
325,000 | 305,913 | ||||||
| 5,633,120 | 5,315,143 | |||||||
|
Less: Current portion
|
$ | 4,400,690 | $ | 4,127,545 | ||||
|
Long-term portion
|
$ | 1,232,430 | $ | 1,187,598 | ||||
|
Year Ending February 28,
|
||||
|
2015
|
$ |
-
|
||
|
2016
|
-
|
|||
|
2017
|
1,232,430
|
|||
|
Total
|
$ |
1,232,430
|
||
|
August 31, 2014
|
February 28, 2014
|
|||||||
|
Accrued payroll and related expenses
|
$ | 2,223,401 | $ | 2,729,944 | ||||
|
Accrued rent
|
208,735 | 198,111 | ||||||
|
Accrued interest
|
818,164 | 456,801 | ||||||
|
Other
|
8,982 | 1,079 | ||||||
|
Total
|
$ | 3,259,282 | $ | 3,385,937 | ||||
|
2006 Plan
|
|||||||
|
Weighted-Average Exercise Price
|
Aggregate Intrinsic Value
|
Number of Options
|
|||||
|
|
|
||||||
|
Outstanding, February 28, 2014
|
$0.75-$1.00
|
$0.00
|
8,602,333
|
||||
|
Cancelled
|
$0.75
|
(825,333)
|
|||||
|
Granted
|
-
|
-
|
|||||
|
Outstanding, August 31, 2014
|
$0.75-$1.00
|
$0.00
|
7,777,000
|
||||
|
Options Outstanding
|
Exercisable Options
|
||||||||||||||||||
|
Range of Exercise
Price
|
Number
|
Weighted Average Remaining Life
|
Weighted Average Exercise Price
|
Weighted Average Remaining Life
|
Number
|
Weighted Average Exercise Price
|
|||||||||||||
|
$0.75-$1.00
|
7,777,000
|
5.4 years
|
$
|
0.79
|
5.5 years
|
7,777,000
|
$
|
0.79
|
|||||||||||
|
Number of Shares
|
Exercise Prices
|
||
|
Outstanding, February 28, 2014
|
48,503,720
|
$0.75-$2.00
|
|
|
Granted
|
17,731,012
|
$0.10-$0.75
|
|
|
Exercised
|
(17,334,540)
|
$0.10
|
|
|
Cancelled
|
(11,768,430)
|
$0.75-$1.50
|
|
|
Outstanding, August 31, 2014
|
37,131,762
|
$0.10-$2.00
|
|
Range of Exercise Prices
|
Stock Warrants Outstanding
|
Stock Warrants Exercisable
|
Weighted-Average Remaining Contractual Life
|
Weighted-Average Exercise Price of Warrants Outstanding
|
Weighted-Average Exercise Price of Warrants Exercisable
|
Intrinsic Value
|
||||||
|
$0.10-$0.75
|
17,731,012
|
17,731,012
|
80 months
|
$0.55
|
$0.55
|
$0.00
|
||||||
|
$0.75
|
1,082,734
|
1,082,734
|
78 months
|
$0.75
|
$0.75
|
$0.00
|
||||||
|
$0.75
|
1,000,000
|
1,000,000
|
68 months
|
$0.75
|
$0.75
|
$0.00
|
||||||
|
$0.75-$1.00
|
5,990,275
|
5,990,275
|
63 months
|
$0.77
|
$0.77
|
$0.00
|
||||||
|
$1.00-$1.25
|
795,000
|
795,000
|
25 months
|
$1.05
|
$1.05
|
$0.00
|
||||||
|
$1.00
|
8,272,187
|
8,272,187
|
23 months
|
$1.00
|
$1.00
|
$0.00
|
||||||
|
$1.50
|
105,000
|
105,000
|
19 months
|
$1.50
|
$1.50
|
$0.00
|
||||||
|
$0.75-1.50
|
709,198
|
709,198
|
16 months
|
$1.25
|
$1.25
|
$0.00
|
||||||
|
$1.50
|
156,000
|
156,000
|
12 months
|
$1.50
|
$1.50
|
$0.00
|
||||||
|
$1.50
|
704,000
|
704,000
|
11 months
|
$1.50
|
$1.50
|
$0.00
|
||||||
|
$1.50
|
350,642
|
350,642
|
8 months
|
$1.50
|
$1.50
|
$0.00
|
||||||
|
$2.00
|
235,714
|
235,714
|
2 months
|
$2.00
|
$2.00
|
$0.00
|
||||||
|
37,131,762
|
37,131,762
|
|
2014
|
2013
|
|||||||
|
United States
|
$ | 487,455 | $ | 1,150,137 | ||||
|
Canada
|
83,117 | 78,961 | ||||||
|
Europe
|
33,526 | 24,218 | ||||||
|
Asia
|
306,559 | 161,849 | ||||||
|
Other
|
49,865 | 8,750 | ||||||
|
Total
|
$ | 960,522 | $ | 1,423,915 | ||||
|
·
|
Our ability to generate positive cash flow from operations;
|
|
·
|
Our ability to obtain additional financing to fund our operations;
|
|
·
|
Our business development and operating development; and
|
|
·
|
Our expectations of growth in demand for our products.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|